115 related articles for article (PubMed ID: 10226517)
1. Prevalence of human papilloma virus DNA in head and neck cancers carrying wild-type or mutant p53 tumor suppressor genes.
Adams V; Schmid S; Zariwala M; Schmid M; Kleihues P; Briner J; Schäfer R
Anticancer Res; 1999; 19(1A):1-6. PubMed ID: 10226517
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer.
Brachman DG; Graves D; Vokes E; Beckett M; Haraf D; Montag A; Dunphy E; Mick R; Yandell D; Weichselbaum RR
Cancer Res; 1992 Sep; 52(17):4832-6. PubMed ID: 1324797
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma.
Sisk EA; Soltys SG; Zhu S; Fisher SG; Carey TE; Bradford CR
Head Neck; 2002 Sep; 24(9):841-9. PubMed ID: 12211048
[TBL] [Abstract][Full Text] [Related]
4. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival.
Haraf DJ; Nodzenski E; Brachman D; Mick R; Montag A; Graves D; Vokes EE; Weichselbaum RR
Clin Cancer Res; 1996 Apr; 2(4):755-62. PubMed ID: 9816227
[TBL] [Abstract][Full Text] [Related]
5. Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer.
Moonen PM; Bakkers JM; Kiemeney LA; Schalken JA; Melchers WJ; Witjes JA
Eur Urol; 2007 Aug; 52(2):464-8. PubMed ID: 17116360
[TBL] [Abstract][Full Text] [Related]
6. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
[TBL] [Abstract][Full Text] [Related]
7. Carcinoma of the vulva: HPV and p53 mutations.
Lee YY; Wilczynski SP; Chumakov A; Chih D; Koeffler HP
Oncogene; 1994 Jun; 9(6):1655-9. PubMed ID: 8183560
[TBL] [Abstract][Full Text] [Related]
8. p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy.
Ganly I; Soutar DS; Brown R; Kaye SB
Br J Cancer; 2000 Jan; 82(2):392-8. PubMed ID: 10646894
[TBL] [Abstract][Full Text] [Related]
9. p53 mutations and presence of HPV DNA do not correlate with radiosensitivity of gynecological cancer cell lines.
Rantanen V; Grénman S; Kurvinen K; Hietanen S; Raitanen M; Syrjänen S
Gynecol Oncol; 1998 Dec; 71(3):352-8. PubMed ID: 9887230
[TBL] [Abstract][Full Text] [Related]
10. Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck.
Westra WH; Taube JM; Poeta ML; Begum S; Sidransky D; Koch WM
Clin Cancer Res; 2008 Jan; 14(2):366-9. PubMed ID: 18223210
[TBL] [Abstract][Full Text] [Related]
11. Human papillomavirus genome detection by in situ hybridization in fine-needle aspirates of metastatic lesions from head and neck squamous cell carcinomas.
Umudum H; Rezanko T; Dag F; Dogruluk T
Cancer; 2005 Jun; 105(3):171-7. PubMed ID: 15822131
[TBL] [Abstract][Full Text] [Related]
12. The prognostic significance of HPV-16 genome status of the lymph nodes, the integration status and p53 genotype in HPV-16 positive cervical cancer: a long term follow up.
Hernádi Z; Szarka K; Sápy T; Krasznai Z; Veress G; Póka R
BJOG; 2003 Feb; 110(2):205-9. PubMed ID: 12618167
[TBL] [Abstract][Full Text] [Related]
13. Expression of p16(INK4A), p53, and Rb proteins are independent from the presence of human papillomavirus genes in oral squamous cell carcinoma.
Nemes JA; Deli L; Nemes Z; Márton IJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Sep; 102(3):344-52. PubMed ID: 16920543
[TBL] [Abstract][Full Text] [Related]
14. [Causal association between human papilloma virus infection and head and neck and esophageal squamous cell carcinoma].
Szentirmay Z; Szántó I; Bálint I; Pólus K; Remenár E; Tamás L; Szentkúti G; Melegh Z; Nagy P; Kásler M
Magy Onkol; 2002; 46(1):35-41. PubMed ID: 12050680
[TBL] [Abstract][Full Text] [Related]
15. Is the p53 inactivation frequency in squamous cell carcinomas of the head and neck underestimated? Analysis of p53 exons 2-11 and human papillomavirus 16/18 E6 transcripts in 123 unselected tumor specimens.
Balz V; Scheckenbach K; Götte K; Bockmühl U; Petersen I; Bier H
Cancer Res; 2003 Mar; 63(6):1188-91. PubMed ID: 12649174
[TBL] [Abstract][Full Text] [Related]
16. A c-rasHa mutation in the metastasis of a human papillomavirus (HPV)-18 positive penile squamous cell carcinoma suggests a cooperative effect between HPV-18 and c-rasHa activation in malignant progression.
Leis PF; Stevens KR; Baer SC; Kadmon D; Goldberg LH; Wang XJ
Cancer; 1998 Jul; 83(1):122-9. PubMed ID: 9655301
[TBL] [Abstract][Full Text] [Related]
17. Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53.
Rady PL; Schnadig VJ; Weiss RL; Hughes TK; Tyring SK
Laryngoscope; 1998 May; 108(5):735-40. PubMed ID: 9591556
[TBL] [Abstract][Full Text] [Related]
18. Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control.
Wiest T; Schwarz E; Enders C; Flechtenmacher C; Bosch FX
Oncogene; 2002 Feb; 21(10):1510-7. PubMed ID: 11896579
[TBL] [Abstract][Full Text] [Related]
19. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
[TBL] [Abstract][Full Text] [Related]
20. The characteristics of human papillomavirus DNA in head and neck cancers and papillomas.
Major T; Szarka K; Sziklai I; Gergely L; Czeglédy J
J Clin Pathol; 2005 Jan; 58(1):51-5. PubMed ID: 15623482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
